e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome
Z. He, X. Guo (Beijing, China)
Source:
Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Session:
Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Session type:
Thematic Poster Session
Number:
1069
Disease area:
Pulmonary vascular diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. He, X. Guo (Beijing, China). Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome. Eur Respir J 2008; 32: Suppl. 52, 1069
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020
Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006
Vasoconstriction during the night in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 419s
Year: 2006
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS)
Source: Eur Respir J 2004; 24: Suppl. 48, 565s
Year: 2004
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012
Association between obstructive sleep apnea hypopnea and metabolic syndromes
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Evaluation of the effect of inspirational muscle training in patients with apnea and hypopnea sleep obstructive syndrom
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept